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cardiogenic shock from all published randomized trials (RCTs) to date.
METHODS To identify all RCTs of IABP therapy, public databases
including MEDLINE (1966 to 2014) and EMBASE (1980 to 2014) were
searched. The search was restricted to human studies and clinical
trials or randomized controlled trials only. In addition, we also
manually searched bibliographies of identiﬁed studies if needed.
References were screened for studies that compared the use of IABP in
AMI with or without cardiogenic shock. Data extraction was carried
out independently and in duplicates.
RESULTS Seventeen relevant studies met the inclusion criteria and
3226 participants were enrolled in our study after in-depth review. We
analyzed the impact of IABPmanagement on short-termmortality in 14
trials (2354 patients), long-term mortality in 9 trials (1743 patients).
There was no signiﬁcant difference on short-term mortality (less than
30-day mortality) between IABP on AMI patients with cardiogenic
shock and control group (RR, 0.91; 95% CI, 0.77–1.08; P¼0.293). Similar
result was also observed in AMI patients without cardiogenic shock
(RR, 0.88; 95% CI, 0.60–1.29; P¼0.279). Taken together, the short-term
mortality of patients with AMI with and without cardiogenic shock
does not differ between IABP and control group (RR, 0.90; 95%CI, 0.77–
1.06; p¼0.214). Interestingly, further analysis of two subgroups in 9
studies (4 AMI trials with cardiogenic shock and 5 without cardiogenic
shock) also demonstrated that IABP therapy was not associated with a
signiﬁcantly reduced risk of long-term mortality (6- and 12-month
mortality) rate (RR, 0.91; 95% CI, 0.79–1.04; P ¼0.155). Similar results
were shown when the analyses were performed on patients with (RR,
0.95; 95% CI, 0.83–1.10; P¼0.492) or without cardiogenic shock (RR,
0.73; 95% CI, 0.49–1.09; P¼0.122), respectively.
CONCLUSIONS As far as we know, this is the ﬁrst updated meta-
analysis of only randomized controlled trials including IABP-SHOCK II
trial. We did not observe substantial beneﬁt from IABP use in AMI
patients with or without cardiac shock in reducing the short-term and
long-term mortality rate. However, AMI is not only associated with
compromised cardiac contractile function, especially in patients with
cardiogenic shock. Other than mortality, more comprehensive
assessment of hemodynamic changes or laboratory inﬂammatory
markers may serve as better end points. Therefore, future RCTs with
larger numbers of patients and rigorous design are required.
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Relationship Between Myocardial Perfusion and Vascular Endothelial
Function in Patients with Non-ST-Segment Elevation Acute Coronary
Syndrome
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OBJECTIVES Endothelial function plays a key role in determining the
clinical manifestations of atherosclerotic lesions. This study aimed to
investigate the relationship between endothelial function and
myocardial perfusion before or after percutaneous coronary inter-
vention (PCI) in patients with non-ST-elevation acute coronary syn-
drome (NSTE-ACS).
METHODS 172 patients, with high-risk NSTE-ACS were measured
levels nitric oxide (NO) and endothelin (ET), and detected the brachial
artery ﬂow-mediated vasodilation (FMD) before PCI. The angiographic
data was analyzed before and after PCI, in terms of TIMI myocardial
perfusion grade in the area of culprit vessels.
RESULTS Before PCI, 78 patients with TMPG 1w2 had lower NO levels
(44.16mmol/L7.46mmol/L vs. 52.25mmol/L5.17mmol/L, P¼0.042),
and lower FMD (2.261.83% vs. 3.451.43%, P¼0.028) than those with
TMPG 2w3, while the levels of ET were not different (p¼0.462). After
PCI, 47 patients with TMPG 1w2 had lower NO levels (42.64mmol/
L8.58mmol/L vs. 54.87mmol/L7.30mmol/L, P¼0.031), and lower FMD
(2.031.25% vs. 3.661.38%, P¼0.020) than those with TMPG 2w3.
CONCLUSIONS Lower NO levels and lower FMD can be measured
before PCI in those high-risk NSTE-ACS patients with poor myocardial
perfusion pre- or post-PCI, which indicated more damaged endothe-
lial function in poor myocardial perfusion patients with NSTE-ACS.
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OBJECTIVES Fractional ﬂow reserve (FFR) is currently considered the
gold standard for evaluating the functional signiﬁcance of coronary
stenosis. However, its potential beneﬁts in real-world practice remain
unknown in China.
METHODS A retrospective cohort study was carried out using the
EMRS database of The Second Afﬁliated Hospital of Zhejiang Univer-
sity, a tertiary and high-volume center in China. Clinical events were
compared using the Cox proportional hazards model during a median
follow-up of 13 months.
RESULTS The study cohort consisted of 366 consecutive patients
referred for coronary revascularization with adjunct FFR and 366
matched controls, from 2010 to 2014. Major adverse cardiac events
(death, myocardial infarction, repeated revascularization, or hospi-
talization for angina) at 4 years were found in 12.0% of angiography-
guided patients and 4.9% in the FFR-guided group (p<0.001). The
mean number of implanted stents was signiﬁcantly lower in FFR
treated subjects (0.520.82 stents) compared with the angiography-
guided group (0.930.96 stents) (P<0.001). No difference in overall
costs at initial hospitalization was observed between angiography-
guided percutaneous coronary intervention (PCI) compared with
FFR-guided PCI (￥33000, range 7393-44700) versus￥21200 (￥19100-
47100) (p¼0.54). How ever, mean costs for major adverse cardiac
events during follow-up were signiﬁcantly reduced in the FFR-guided
arm (￥1688 9554 versus ￥344112873, p<0.001).
CONCLUSIONS In the contemporary clinical practice, FFR-guided PCI
is associated with decreased use of stents, improved clinical outcome,
and reduced costs, compared with angiography-guided PCI.GW26-e4423
Analysis of the risk factors and characteristics of coronary artery disease of
Han, Uygur and Kazak patients with acute myocardial infarction in Xinjiang
Jiao Wang Muhuyati
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OBJECTIVES To discuss the risk factors and characteristics of coro-
nary artery disease of Han, Uygur and Kazak patients with acute
myocardial infarction in Xinjiang district.
METHODS A retrospective analysis of clinical data of 262 cases of Han
patients, 166 cases of Uygur patients and 86 cases of Kazak patients
was conducted, whose age, body mass index, cholesterol, uric acid,
hypertension, type 2 diabetes, smoking, drinking, family history of
coronary heart disease, relationship between PCI history and patho-
genesis of acute myocardial infarction, and coronary artery disease
characteristics were observed and compared in different groups.
RESULTS Between the Han and minority young patients, there were
statistically signiﬁcant differences in the distribution of BMI, lipo-
protein a, positive family history of coronary heart disease, uric acid
level, the combined aspects of smoking history (P <0.017); there were
also statistically signiﬁcant differences in BMI, TG, HDL-C, apolipo-
protein B, positive family history of coronary heart disease distribu-
tion between minority young patients and older patients (P <0.017).
There were statistically signiﬁcant differences in the distribution of
BMI, TC, HDL-C, LDL-C, apolipoprotein AI, positive family history of
coronary heart disease between Han and Uygur patients (P <0.017).
Han and Kazak patients had statistically signiﬁcant differences in the
distribution of BMI, TC, LDL-C, apolipoprotein B, lipoprotein a, type 2
diabetes and hypertension (P <0.017). Comparison of patients in
Uygur and Kazak showed that there were statistically signiﬁcant dif-
ferences in the distribution of BMI, TC, LDL-C, apolipoprotein AI,
apolipoprotein B and type 2 diabetes between the two groups
(P <0.017). The proportion of zero lesions and single-vessel lesions in
minority youth patients was higher than that of elderly patients
(P <0.001), and the proportion of two and three lesions was less than
that of elderly patients (P <0.001). Gensini score of Han patients was
greater than that of Uygur patients (P <0.001) and the Kazak patients
(P ¼ 0.005); The proportion of Han patients with single-vessel disease
was less than that of Kazak patients (P ¼ 0.003), and the proportion of
patients with double-vessel disease was greater than that of Kazak
patients (P ¼ 0.007). The logistic show that: the risk factors of mi-
nority youth are TG (OR ¼30.793), smoking (OR ¼6.203), hypertension
(OR ¼4.49), hyperuricemia (OR¼2.913) (P <0.05).
CONCLUSIONS There were ethnic differences in risk factors and the
characteristics of coronary artery disease of AMI patients in Xinjiang
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elderly patients, young patients of Han.GW26-e4737
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OBJECTIVES Diabetics with acute myocardial infarction (AMI) have a
higher risk of adverse outcomes because of complicated factors. Our
aim was to investigate the impact of diabetes on the long-term prog-
nosis in patients with non ST-elevation myocardial infarction
(NSTEMI) patients in the current era.
METHODS From 2002 to 2013, a total of 2080 patients diagnosed of
NSTEMI were retrospectively evaluated in the Cardiology Department
of the First Afﬁliated Hospital of Dalian Medical University. Uniﬁed
follow-up questionnaire was used to visit the NSTEMI patients by
telephone contact (cut-off date was October, 2014). We compared
hospital care data and prognosis between diabetic and nondiabetic
patients.
RESULTS Diabetic patients accounted for 38.6% (n¼803). Compared
with nondiabetic patients, Diabetic ones were more likely to be
older (71.0 vs. 67.0; P <0.001), female (47.6% vs. 29.8%; P <0.001),
and to have hypertension (80.4% vs.60.3%, P <0.001), prior cere-
brovascular disease (6.2% vs. 3.3%, P ¼0.002) and renal insufﬁ-
ciency (36.5% vs. 24.9%, P <0.001) and killip 3 (16.1% vs. 8.1,
P <0.001).
The median follow-up time was 3.1 years.. Diabetic patients showed
higher mortality (32.4% vs.20.9%; P <0.001 ) and secondary endpoint
(the composite end point) rates (52.4% vs. 40.7%; P <0.001) than
nondiabetic patients.
After controlling for other variables, diabetes was associated with
higher mortality (adjusted RR: 1.277; 95%CI: 1.035-1.575) and second-
ary endpoint rates (adjusted RR: 1.255; 95%CI: 1.081-1.458) (HR¼2.118,
95%CI: 1.572-2.854, P <0.001).
In the subgroup analysis according to percutaneous coronary
intervention (PCI), there were no differences in mortality (4.6% vs.
3.5%; P ¼0.475) and secondary endpoint rates (27.2% vs. 24.6%;
P ¼0.464) between diabetic and nondiabetic patients. After control-
ling for other variables, diabetes was no longer the independent risk
factor of mortality (adjusted RR: 1.468; 95CI: 0.664-3.244; P ¼0.342),
but the independent risk factor of secondary endpoint rates. (adjusted
RR: 1.492; 95%CI: 1.055-2.111; P ¼0.024).
CONCLUSIONS The diabetic patients with NSTEMI had worse prog-
nosis. However, PCI therapy narrowed the gap of the prognosis be-
tween diabetic and non-diabetic NSTEMI patients.GW26-e1312
Changes of Expression of HMGB1 Interferenced with atorvastatin in acute
ST-segment elevation myocardial infarction patients with 2-type Diabetes
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OBJECTIVES To observe atorvastatin mediated inﬂammatory factor
HMGB1 in patient of acute ST-segment elevation myocardial infarc-
tion with 2-type Diabetes.
METHODS 226 patients with consecutive elections ST-segment
elevation acute myocardial infarction with 2-type Diabetes were
collected from January 2008 to December 2014, aged 27-90 years old,
ruled out infectious diseases, cancer, collagen diseases, application of
immunosuppressive drugs. All patients underwent emergency coro-
nary intervention, were randomly divided into control group and
early intervention atorvastatin group (undergoing emergency percu-
taneous coronary intervention 30 minutes to 1 hour after oral
administration of atorvastatin 80mg), ELISA was used to measure the
contents of HMGB1.
RESULTS 1. The levels of HMGB1 in two groups increased 24 hours
after PCI ( P <0.01); 2. The levels of HMGB1 in the intervention group
was statistically signiﬁcant compared with the control group 24 hours
later.
CONCLUSIONS High-dose atorvastatin used i in patient of acute ST-
segment elevation myocardial infarction with 2-type Diabetes before
percutaneous coronary intervention promotes HMGB1 levels drop,
reduce inﬂammatory response in patients.GW26-e0198
The analysis of clinical characteristics of Debakey I aortic dissection Injury
the left main coronary artery
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OBJECTIVES Analysis the characteristics of Debakey I aortic dissec-
tion injury the left main coronary artery.
METHODS Collected the clinical data of patients in our hospital in
recent 5 years, diagnosed as Debakey I aortic dissection injured the
left main coronary artery, All patients through the aortic CTA
diagnosed.
RESULTS Debakey I aortic dissection injured the left main coronary
artery shows a typical ECG expression of the Coronary heart disease
with Left main coronary lesions, Confused easily with acute non ST
segment elevation myocardial infarction, But the age of onset of chest
pain is younger, more serious, often accompanied by backache,
careful physical examination can also ﬁnd hints of aortic dissection
information, besides, troponin levels, previous chest pain history and
ECG dynamic changes have certain difference.
CONCLUSIONS Debakey I aortic dissection is a critical cardiovascular
diseases, Often injured the right coronary artery, caused acute inferior
myocardial infarction. Left main coronary artery injured is rare but
very dangerous. And easily misdiagnosed as acute coronary syndrome
treated with serious consequences, ECG expression of the Coronary
heart disease with Left main coronary lesions Should exclude aortic
dissection Firstly.GW26-e1510
Approach of Determining Culprit Vessel in acute inferior myocardial
infarction by ECG
Chunlin Huang
Xinfeng County People Hospital
OBJECTIVES According to the indexes of electrocardiogram in the
patient who with acute inferior wall myocardial infarction, analyze
the judging process to identifying the Culprit Vessel.
METHODS 193 patient who with acute inferior myocardial infarction
were admitted into the study, According to the results of CAG divided
into RCA occlusion group and LCX occlusion group, Analysis the In-
dexes of ECG, summarize the diagnosis process of IRA.
RESULTS 1. The approach to determine RCA or LCX of culprit vessels:
step 1: ST[0.05mv in lead V4R or IIIAVB is a sign to identify RCA.
Step 2: STY0.05mv in lead I and AVL is a sign to identify RCA; ST[ or
equipotential line in lead I and AVL is a sign to identify LCX. Step 3:
ST[ in lead II /ST[in lead III 1 is a sign to identify LCX. Step 4: SSTY
in lead V1, V2 and V3/SST[ in lead II, III and AVF1 is a sign to identify
RCA; SSTY in lead V1, V2 and V3/SST[ in lead II, III and AVF>1 is a
sign to identify LCX.
CONCLUSIONS ECG analysis can determine the part of culprit vessel
in a rapid and accurate way.GW26-e1578
The glycated hemoglobin Alc (HbA1c) levels and the prognosis after PCI in
postmenopausal women with acute coronary syndrome and diabetes
Xin Zou, Peng Qu
the second Afﬁliated Hospital of Dalian Medical University
OBJECTIVES To explore the inﬂuence of glycated hemoglobin Alc
(HbA1c) levels on clinical outcomes in postmenopausal women with
acute coronary syndrome and diabetes after percutaneous coronary
intervention (PCI).
METHODS We selected 675 consecutive ﬁrst hospitalized patients
with acute coronary syndrome (ACS) during January 2008 to January
2013 in the hospital. All the patients were postmenopausal women
(55 years old) and preformed PCI treatment. According to HbA1c
levels and diagnosis of diabetes, patients were divided into 3 groups:
non-diabetics (A group, N¼373), good-control diabetics(B group,
HbA1c<7.0%, N¼75), poor-control diabetics (C group, HbA1c7.0%,
N¼154). Patients information was collecteded,12 hours of fasting pe-
ripheral venous blood was taken to detect glycated hemoglobin,
fasting blood glucose, blood lipids, etc. According to the image of
coronary artery angiography, the SYNTAX score was calculated, after
PCI the number and length of implanted stent was recorded. All
